chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: HEPAB
Symptoms: Incomplete course of vaccination
Clinical narrative: inappropriate schedule of vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a elderly male patient who received HAB (Twinrix) for prophylaxis.   Previously administered products included Twinrix (received 1st dose on 29th February 2024).   On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: inappropriate schedule of vaccine). The outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 12-JUN-2024 The pharmacist reported a patient received the first dose of Twinrix and has not received the 2nd dose yet, which led to incomplete course of vaccination. Consented to follow up.
Sex: U
Vaccine: DTAP, DTAPHEPBIP, DTAPIPV, HEP, HEPA
Symptoms: Product storage error
Clinical narrative: Administration after temp excursion; This non-serious case was reported by a physician via call center representative and described the occurrence of incorrect storage of drug in a patient who received DTPa (Infanrix) for prophylaxis.   Co-suspect products included HBV (Engerix B) for prophylaxis, DTPa-HBV-IPV (Pediarix) for prophylaxis, DTPa-IPV (Kinrix) for prophylaxis and HAV (Havrix) for prophylaxis.   On an unknown date, the patient received Infanrix, Engerix B, Pediarix, Kinrix and Havrix. On an unknown date, an unknown time after receiving Infanrix, Engerix B, Pediarix, Kinrix and Havrix, the patient experienced incorrect storage of drug (Verbatim: Administration after temp excursion). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 12-JUN-2024 The health care professional (HCP) called to ask for information about the stability of Infanrix, Engerix-B, Pediarix, Kinrix, Havrix vaccines exposed to -3.3 Degree Celsius.  Vaccines were out of range for 15min on Jun 10th 2024. The HCP mentioned that some of these vaccines probably have been adminsitered but they need to doublecheck to confirm the vaccines adminsitered and the number of patients who received these vaccines. The patient received vaccine after temperature excursion, which led to incorrect product storage error.  Consented to follow up.
Sex: U
Vaccine: MNQ
Symptoms: Product preparation error
Clinical narrative: Incorrect diluent; Inappropriate dose of vaccine administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: Incorrect diluent) and inappropriate dose of vaccine administered (Verbatim: Inappropriate dose of vaccine administered). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 12-JUN-2024 The pharmacist reported that the patient was administered a Menveo vaccine to a patient and reconstituted with the diluent of the MMR vaccine, which led to wrong solution used and inappropriate dose of vaccine administered and inappropriate dose of vaccine administered. Did not consent to follow-up.
Age: 0.58
Sex: M
Vaccine: HIBV
Symptoms: Product preparation error
Clinical narrative: patient was given Hiberix with a Merck diluent instead the one from GSK; patient was given Hiberix with a Merck diluent instead the one from GSK; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 7-month-old male patient who received Hib (Hiberix) (batch number 397D3, expiry date 15-MAR-2026) for prophylaxis.   On an unknown date, the patient received Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced wrong solution used in drug reconstitution (Verbatim: patient was given Hiberix with a Merck diluent instead the one from GSK) and inappropriate dose of vaccine administered (Verbatim: patient was given Hiberix with a Merck diluent instead the one from GSK). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 12-JUN-2024 7 month old patient was given Hiberix with a Merck diluent instead the one from GlaxoSmithKline which led to Wrong solution used in drug reconstitution and Inappropriate dose of vaccine administered.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Expired product administered
Clinical narrative: Expired dose administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number 477X5, expiry date 27-MAY-2024) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On 12-JUN-2024, the patient received the 2nd dose of Shingrix. On 12-JUN-2024, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: Expired dose administered). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 13-JUN-2024 It was reported that a patient who was due for the 2nd dose, the vaccine was given day before reporting which was the 12th, but then they realized the vaccine was already expired which led to expired vaccine used.
Age: 75.0
Sex: F
Vaccine: HEPA
Symptoms: Inappropriate schedule of product administration
Clinical narrative: late 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 75-year-old female patient who received HAV (Havrix) (batch number 772YT, expiry date 23-SEP-2025) for prophylaxis.   Previously administered products included Havrix (1st dose received in January 2018).   On 12-JUN-2024, the patient received the 2nd dose of Havrix. On 12-JUN-2024, an unknown time after receiving Havrix, the patient experienced drug dose administration interval too long (Verbatim: late 2nd dose). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 13-JUN-2024 The patient received 2nd dose of Havrix, later than the recommended interval, which led to lengthening of vaccinations schedule. (Drug dose administration interval too long) plus 7 days.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Expired product administered
Clinical narrative: Administration of an expired dose of Priorix; This non-serious case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a 12-month-old female patient who received MMR (Priorix) (batch number 3247X, expiry date 11-MAY-2024) for prophylaxis.   On 05-JUN-2024, the patient received Priorix. On 05-JUN-2024, an unknown time after receiving Priorix, the patient experienced expired vaccine used (Verbatim: Administration of an expired dose of Priorix). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 13-JUN-2024 An Healthcare professional called to report the administration of an expired Priorix dose to a patient which led to expired vaccine used. The HCP asked for guidance on this situation.
Age: 0.33
Sex: U
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered, No adverse event
Clinical narrative: 4 month old patient was administered with expired pentacel with no reported ae; Initial information received on 06-Jun-2024 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 4 months old and unknown gender patient who was administered with expired Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine [Pentacel (Vero)] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the 4 months old patient received a unknown expired dose of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine Suspension for injection (expiry date: 19-Feb-2024, strength  and lot number not reported) via unknown route in unknown administration site as Immunization (expired product administered) (same day latency).   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: MNQ
Symptoms: Expired product administered
Clinical narrative: administered 2 months after the expiration date of 31-MAR-2024; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received Men ACWY-CRM NVS (Menveo) (expiry date 31-MAR-2024) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: administered 2 months after the expiration date of 31-MAR-2024). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 07-JUN-2024 The pharmacist reported that, a dose of Menveo, one vial presentation was administered 2 months after the expiration date, which led to expired vaccine used. The reporter did not had any patient demographics to provided. The reporter did not had lot or NDC to verify the product. The reporter did not had information about the administration of the expired dose, route, or date of administration.  The reporter consented to follow up.
Sex: F
Vaccine: HEPA
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: got her a second dose but made of 0.5ml of an adult 1ml dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult product administered to child in a 15-year-old female patient who received HAV (Havrix 1440 adult) for prophylaxis.   Previously administered products included Havrix junior (received 1st dose on 11th November 2023, 0.5 ml).   On 15-MAY-2024, the patient received the 2nd dose of Havrix 1440 adult .5 ml. On 15-MAY-2024, an unknown time after receiving Havrix 1440 adult, the patient experienced adult product administered to child (Verbatim: got her a second dose but made of 0.5ml of an adult 1ml dose). The outcome of the adult product administered to child was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 07-JUN-2024 The other health professional had a 15 year old patient that got her first 0.5ml pediatric dose of Havrix shot and then she got her a second dose but made of 0.5ml of an adult 1ml dose, which led to adult product administered to child. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up.
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration, Product leakage, Underdose
Clinical narrative: half of the vaccine leaked; Second dose was administered more than 6 months later; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of underdose in a 73-year-old male patient who received Herpes zoster (Shingrix) (batch number 4PN99, expiry date 20-AUG-2024) and (batch number LY93M, expiry date 09-JUN-2026) for prophylaxis.   Previously administered products included shingrix (on 30th August 2023 received 1st dose).   On 13-JUN-2024, the patient received the 2nd dose of Shingrix. On 13-JUN-2024, an unknown time after receiving Shingrix, the patient experienced underdose (Verbatim: half of the vaccine leaked) and drug dose administration interval too long (Verbatim: Second dose was administered more than 6 months later). The outcome of the underdose and drug dose administration interval too long were unknown.   Additional Information: GSK Receipt date: 13-JUN-2024 A pharmacist reported that they were administering a second dose of Shingrix to a patient on 13 June 2024 but the syringe seemed defective and reporter calculated that half of the vaccine leaked which led to Underdose.  First dose of Shingrix was administered on 30 August 2023, so the second dose was administered more than 6 months later.  The patient received 2nd dose of Shingrix later than the recommended interval, which led to lengthening of the vaccine schedule.
Age: 1.42
Sex: F
Vaccine: HIBV
Symptoms: No adverse event, Poor quality product administered, Product preparation error
Clinical narrative: ACTHIB was mixed with the MMR diluent instead of the ACT-HIB diluent with no reported adverse event; ACTHIB was mixed with the MMR diluent instead of the ACT-HIB diluent, was given to a patient with no reported adverse event; Initial information received on 12-Jun-2024 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 17 months and 20 days old female patient who received HIB (PRP/T) Vaccine [ACT-HIB] was mixed with the MMR diluent instead of the ACT-HIB diluent, was given to a patient with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Diphtheria Vaccine Toxoid, Pertussis Vaccine Acellular, Tetanus Vaccine Toxoid (DTAP) for Prophylactic vaccination.  On 11-Jun-2024, the patient received a dose of 0.5 ml of suspect HIB (PRP/T) Vaccine (Powder and solvent for solution for injection) (lot UJ992AA,Expiry date:28-Feb-2025, strength was unknown) via intramuscular route in unknown administration site for prophylactic vaccination (Immunization) and ACTHIB was mixed with the MMR diluent instead of the ACT-HIB diluent was given to a patient with no reported adverse event (product preparation error) and (poor quality product administered) (latency : same day).   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 17.0
Sex: M
Vaccine: HPV9, MENB, MNQ
Symptoms: Blood glucose normal, Dizziness, Fall, Fear, Head discomfort
Clinical narrative: Patient started to walk out after getting his immunizations and he felt lightheaded, and started to fall backwards, father caught him and laid him down to floor. Had a brief episode of shaking- lasting less than 10 seconds. Staff laid him to his side. No LOC, no head injury. Vitals stable- normal BP, Heart rate, SpO2 above 95%.  POC glucose 130. He reported he didn't eat anything in the last 6 hours. He ate 2 eggs and 1 tortilla at 9am. Has been drinking water. He felt scared and bvervous about labs ordered. Patient laid down for few minutes, then sat up, had a juice bottle and some crackers.  C/o head feeling heavy, ears ringing, which resolved in 5 min. HR briefly went in to 50;s, came back within seconds to 60's.  10min later patient reported feeling better, wanted to go home. Sitting up in chair, color appears normal. No SOB. Normal heart sounds. HR 70's    Sent home with father
Age: 17.0
Sex: M
Vaccine: HPV9, MENB, MNQ
Symptoms: Nervousness, Tinnitus, Tremor
Clinical narrative: Patient started to walk out after getting his immunizations and he felt lightheaded, and started to fall backwards, father caught him and laid him down to floor. Had a brief episode of shaking- lasting less than 10 seconds. Staff laid him to his side. No LOC, no head injury. Vitals stable- normal BP, Heart rate, SpO2 above 95%.  POC glucose 130. He reported he didn't eat anything in the last 6 hours. He ate 2 eggs and 1 tortilla at 9am. Has been drinking water. He felt scared and bvervous about labs ordered. Patient laid down for few minutes, then sat up, had a juice bottle and some crackers.  C/o head feeling heavy, ears ringing, which resolved in 5 min. HR briefly went in to 50;s, came back within seconds to 60's.  10min later patient reported feeling better, wanted to go home. Sitting up in chair, color appears normal. No SOB. Normal heart sounds. HR 70's    Sent home with father
Age: 15.0
Sex: F
Vaccine: HPV9
Symptoms: Injection site nodule, Injection site pain
Clinical narrative: Initial pain at the site and small nodule developed a day after the vaccine. Persistent pain and nodule, improving by the time we saw her one month later but still there.
Age: 57.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Death
Clinical narrative: PATIENT REPORTED CHILLS NEXT DAY, AND PASSED AWAY IN HIS SLEEP THAT EVENING
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Rash
Clinical narrative: Patient received Kinrix, MMR and Varicella vaccines on 6/04/2024. On 6/14/2024 mom noticed rash on his face/cheeks, then on 6/15/2024, rash spread to forehead area, then on 6/16/24 rash spread to trunk. Per mom patient ate shrimp on  6/13/2024. The first time he ate shrimp at age 1 and had a rash. After that he had shrimp again at age 3 but did not have a reaction.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC20, RV5
Symptoms: Abdominal X-ray, Blood culture, Blood glucose, Blood test, C-reactive protein
Clinical narrative: Infant started on 6/12/24 to have decreased intake, then started to vomit. Was having large emesis overnight. Then started to refuse to breast feed at all, which was very unusual for infant. Infant brought to PCP office on 6/13/24 and had not had a wet diaper for over 7 hours. Infant sent to local ER for dehydration evaluation and management. In ER, infant continued to refuse to nurse and concern for intussusception was raised. Infant was then transferred to larger facility where ileocolic intussusception was found and reduced with an air enema.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC20, RV5
Symptoms: Chest X-ray, Decreased appetite, Differential white blood cell count, Enema administration, Full blood count
Clinical narrative: Infant started on 6/12/24 to have decreased intake, then started to vomit. Was having large emesis overnight. Then started to refuse to breast feed at all, which was very unusual for infant. Infant brought to PCP office on 6/13/24 and had not had a wet diaper for over 7 hours. Infant sent to local ER for dehydration evaluation and management. In ER, infant continued to refuse to nurse and concern for intussusception was raised. Infant was then transferred to larger facility where ileocolic intussusception was found and reduced with an air enema.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC20, RV5
Symptoms: Intussusception, Liver function test, Metabolic function test, Procalcitonin, Ultrasound abdomen
Clinical narrative: Infant started on 6/12/24 to have decreased intake, then started to vomit. Was having large emesis overnight. Then started to refuse to breast feed at all, which was very unusual for infant. Infant brought to PCP office on 6/13/24 and had not had a wet diaper for over 7 hours. Infant sent to local ER for dehydration evaluation and management. In ER, infant continued to refuse to nurse and concern for intussusception was raised. Infant was then transferred to larger facility where ileocolic intussusception was found and reduced with an air enema.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC20, RV5
Symptoms: Urine analysis, Vomiting, X-ray
Clinical narrative: Infant started on 6/12/24 to have decreased intake, then started to vomit. Was having large emesis overnight. Then started to refuse to breast feed at all, which was very unusual for infant. Infant brought to PCP office on 6/13/24 and had not had a wet diaper for over 7 hours. Infant sent to local ER for dehydration evaluation and management. In ER, infant continued to refuse to nurse and concern for intussusception was raised. Infant was then transferred to larger facility where ileocolic intussusception was found and reduced with an air enema.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: No adverse event, Product preparation error
Clinical narrative: There were no adverse events, however the medication was administered incorrectly. Medication was reconstituted with incorrect suspension component.
Age: 43.0
Sex: F
Vaccine: HPV9
Symptoms: Arthralgia, Discomfort, Dizziness, Hyperhidrosis, Injection site pain
Clinical narrative: On March 25, 2024, I received my second of three Gardasil shots.  As I was being given the shot, I felt intense pain down my arm in to the tip of my middle finger.  I broke out into a sweat, became nauseous, and told the nurse I thought I was going to pass out.  She helped me across the hall to a room with a bed.  I began to dry heave.  She eventually got me settled on a bed with a cool rag and some crackers.  After about 20 minutes, I was able to leave the clinic on my own.  Over the next several days, I had some pain that I attributed to normal vaccination pain.  Over the following weekend, the pain increased in my shoulder to the point that I could not sleep or get comfortable.  I was told by my gynecologist?s office that sometimes a nerve can be hit to give it some time.  I followed up with my PCP on June 17, 2024, because I was still having significant issues with my shoulder.
Age: 43.0
Sex: F
Vaccine: HPV9
Symptoms: Nausea, Retching, Sleep disorder
Clinical narrative: On March 25, 2024, I received my second of three Gardasil shots.  As I was being given the shot, I felt intense pain down my arm in to the tip of my middle finger.  I broke out into a sweat, became nauseous, and told the nurse I thought I was going to pass out.  She helped me across the hall to a room with a bed.  I began to dry heave.  She eventually got me settled on a bed with a cool rag and some crackers.  After about 20 minutes, I was able to leave the clinic on my own.  Over the next several days, I had some pain that I attributed to normal vaccination pain.  Over the following weekend, the pain increased in my shoulder to the point that I could not sleep or get comfortable.  I was told by my gynecologist?s office that sometimes a nerve can be hit to give it some time.  I followed up with my PCP on June 17, 2024, because I was still having significant issues with my shoulder.
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site inflammation, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Patient reported "my mom has a systemic inflammatory response to the prevnar vaccine. The site of injection is swollen and the redness is about the size of a football. Stated that the rash has remained on arm for 1 week, appears red, warm to the touch, swollen and inflamed. States that the rash is 7 inches down her arm.
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Systemic inflammatory response syndrome
Clinical narrative: Patient reported "my mom has a systemic inflammatory response to the prevnar vaccine. The site of injection is swollen and the redness is about the size of a football. Stated that the rash has remained on arm for 1 week, appears red, warm to the touch, swollen and inflamed. States that the rash is 7 inches down her arm.
Age: 24.0
Sex: M
Vaccine: FLUA4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient received inappropriate administration of the the Quadrivalent influenza vaccine based on age parameters. Patient did not meet age requirement for this vaccine.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blister, Cardiac failure, Oxygen saturation decreased, Skin exfoliation
Clinical narrative: I have heart failure down to 40%. I have skin problems that serious blister everywhere. My hands are peeling. I have no oxygen in my blood oxygen rate is low.
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: No adverse event
Clinical narrative: No adverse events were reported. Informed senior living contact to monitor patient but none were reported.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Peripheral swelling, Tenderness
Clinical narrative: Left upper arm with swelling,  erythema and tenderness
Age: 21.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Exposure during pregnancy, Extra dose administered
Clinical narrative: Ob patient, 30 wks. 3 days at time of the event. EDD 08/11/2024. Main MA Administered TDAP Vaccine to Pt. and  MA Student Administered a second TDAP vaccine to pt. Student MA asked Main MA if TDAP vaccine was given to pt.  Main MA responded: I gave the Tdap vaccine to a patient and documented but, i don't remember which pt. was (she was busy). Floating Student Ma went to OB patient and in front of  OB doctor asked the OB patient "have you received a TDAP vaccine yet?" Patient responded "No".  MA student administered TDAP and at moment of documenting vaccine she noticed a TDAP vaccine was given no long ago. MA student reported event to provider and supervisor.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 3 yo child, the correct Moderna vaccine of 0.25ml was ordered by provider, however MA administered Moderna vaccine for over 12 years old (0.50ml) to child accidentally.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, Encephalopathy, Hyperkalaemia, Lactic acidosis
Clinical narrative: Hospitalization for Sepsis with suspected CAP, covid positive, lactic acidosis, mild hyperkalemia, AKI, acute encephalopathy on dates 6/5/2024- 6/9/2024. Treated with no COVID medications.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Hospitalization for Sepsis with suspected CAP, covid positive, lactic acidosis, mild hyperkalemia, AKI, acute encephalopathy on dates 6/5/2024- 6/9/2024. Treated with no COVID medications.
Age: 32.0
Sex: F
Vaccine: MMR
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered to patient
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: The vaccine was a pediatric dose (ages 2-11 y/o) versus adult dose
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: Patient received a pediatric dose versus an adult dose
Age: 19.0
Sex: F
Vaccine: HEP, MENB
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient was given Hep B when she was due for MenB, pt was contacted and informed of mistake and came back to get MenB same day.
Age: 1.17
Sex: F
Vaccine: VARCEL
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Vaccine given too early
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Muscular weakness, Pyrexia
Clinical narrative: Patient "woke up with weakened legs and feverish and is unable to get out of the chair". This is the day after COVID vaccine administration.  Patient was taken to hospital for evaluation and subsequently admitted.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Immunisation reaction, Rash, Rash papular
Clinical narrative: 6/17/2024 Spikevax reaction, advised pt to try pfizer next time. pt stated that 2 days later that he had a rash all over his body. raised small bumps, hive like all over skin from immunization on 6/6/24
Age: 72.0
Sex: F
Vaccine: PNC20
Symptoms: Asthenia, Pain in extremity, Rotator cuff syndrome
Clinical narrative: She had debilitating left arm pain after a Prevnar 20 vaccine. She did seek orthopedic consultation who diagnosed her with rotator cuff tendinitis postvaccine.
Age: 4.0
Sex: F
Vaccine: DTAPIPVHIB, IPV, PNC20, VARCEL
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: Pentacel was given. Hib vaccine was recommended. Pt received an unnecessary dose of Dtap and received 2 doses of IPV in one day.
Age: 22.0
Sex: M
Vaccine: IPV, TDAP, TYP, YF
Symptoms: No adverse event, Product preparation error
Clinical narrative: For YF-Vax, sterile water diluent used instead of sterile normal saline. No adverse effects, but patient will need re-vaccination after 28 days (live vaccine) per drug manufacturer (contacted by this provider).
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19-2, COVID19-2, COVID19-2, COVID19-2
Symptoms: Cough, Decreased appetite, Dizziness, Fatigue, Headache
Clinical narrative: Fatigued (for two days), light headed, nauseous, soreness at vaccine site, no appetite, headache. Now have cold symptoms with cough
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19-2, COVID19-2, COVID19-2, COVID19-2
Symptoms: Injection site pain, Nasopharyngitis
Clinical narrative: Fatigued (for two days), light headed, nauseous, soreness at vaccine site, no appetite, headache. Now have cold symptoms with cough
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Asthenia, Chills, Hypoaesthesia, Injection site erythema, Injection site induration
Clinical narrative: Patient has had localized redness, firmness, pain at site of injection for the past 6 weeks without improvement.  She has had intermittent chills and vomiting, weakness and numbness of her left arm.
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site pain, Vomiting
Clinical narrative: Patient has had localized redness, firmness, pain at site of injection for the past 6 weeks without improvement.  She has had intermittent chills and vomiting, weakness and numbness of her left arm.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arrhythmia, Dizziness, Hypotension, Injection site pain, Tachycardia
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Hypotension-Severe, Systemic: Tachycardia-Severe, Additional Details: 74 YEARS OLD MAN WHO RECEIVED 2ND BOOSTER AND HAS A PAST MEDICAL HISTORY FOR A CARDIAC SURGERY 4 YEARS AGO REPORTS ARRHYTMIA AND HYPOTENSION 2 TO 4 HOURS AFTER GETTING THE VACCINE. HE DECREASED TOPROL XL DOSE AND WILL BE DOING A REASSESMENT OF THERAPY. PT IS MD WITH SPECIALTY IN HEMATOLOGY/ONCOLOGY. HE ALSO REPORTED STARTING PHYSICAL ACTIVITY 3 MONTHS AGO WITHOUT ADJUSTING CURENT THERAPY.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Site: Redness at Injection Site-Mild
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Anaphylactic reaction, Rash
Clinical narrative: Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Rash Generalized-Severe, Additional Details: Staff from urgent care contacted pharmacy 6/11/23 to inform of suspected patient reaction to vaccines given. Patient vaccine given approximately 1 pm 6/10/23, no adverse reaction noted. Patient arrived to urgent care approximately 715 pm after noticing a rash reaction around 5 pm. Patient displayed anaphylactic reaction after arrival and transported to emergency room. Patient was monitored and discharged. Pharmacy attempted to contact patient, no contact made., Other Vaccines:  VaccineTypeBrand: Covid Bivalent; Manufacturer: Pfizer; LotNumber: GJ3268; Route: Intramuscular; BodySite: Right Arm; Dose: second booster; VaxDate: 06/10/2023
Age: 36.0
Sex: F
Vaccine: TDAP
Symptoms: Dizziness, Tachycardia
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Tachycardia-Mild, Other Vaccines:  VaccineTypeBrand: Heplisav-B; Manufacturer: Dynavax; LotNumber: 942761; Route: Intramuscular; BodySite: Left Deltoid; Dose: ; VaxDate: UNKNOWN
Age: 26.0
Sex: F
Vaccine: HEPA
Symptoms: Dizziness, Head injury, Loss of consciousness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: Pt had a syncopal event at the counter of the pharmacy after administration. + head strike with brief (<10sec) LOC per witnesses. PT came to and was seated near the pharmacy when this NP evaluated the patient. VS stable and EMS was activated. PT declined transport to hospital and had risks explained to the patient. States that she was feeling back to normal and that she wanted to go home. Patient's father was contacted and accompanied her back home.
Age: 26.0
Sex: F
Vaccine: HEPA
Symptoms: Dizziness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: 911 was called, patient was evaluated, patient was also attended to by our clinic np
Age: 58.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Mild
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: patient reports 4 day migraine and rash
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Migraine, Rash
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: patient reports 4 day migraine and rash
Age: 50.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Rash
Clinical narrative: Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Other Vaccines:  VaccineTypeBrand: MMR; Manufacturer: Merck; LotNumber: w022944; Route: subcutaneous; BodySite: right arm; Dose: 2; VaxDate: 06/10/2023, VaccineTypeBrand: Engerix-B; Manufacturer: GlaxoSmithKline; LotNumber: AX2DS; Route: intermuscular; BodySite: right deltoid; Dose: ; VaxDate: 06/10/2023, VaccineTypeBrand: TPPD test; Manufacturer: Sanofi Pasteur; LotNumber: 2ca92c2; Route: subcutaneous; BodySite: left lower forearm; Dose: ; VaxDate: 06/10/2023
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Immunisation reaction, Injected limb mobility decreased, Injection site pain, Joint range of motion decreased
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: Joint Pain-Severe, Additional Details: Patient received initial dose of Shingrix vaccine, noticed at the time that the injection was given high on the shoulder near the joint, and within a few days was still having pain and couldn't use her left arm much at all.  She discussed with her Dr within a couple weeks of vaccination and Dr wrote it off to side effects from vaccine.  When she arrived to pharmacy on 6/13/23 she mentioned she was still have shoulder pain and limited mobility/range of motion including weakness
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Muscular weakness, Product administered at inappropriate site
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: Joint Pain-Severe, Additional Details: Patient received initial dose of Shingrix vaccine, noticed at the time that the injection was given high on the shoulder near the joint, and within a few days was still having pain and couldn't use her left arm much at all.  She discussed with her Dr within a couple weeks of vaccination and Dr wrote it off to side effects from vaccine.  When she arrived to pharmacy on 6/13/23 she mentioned she was still have shoulder pain and limited mobility/range of motion including weakness
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Chest discomfort, Chest pain
Clinical narrative: Systemic: Chest Tightness / Heaviness / Pain-Medium
Age: 25.0
Sex: F
Vaccine: TDAP
Symptoms: Dizziness, Eye movement disorder, Musculoskeletal stiffness, Nausea, Pallor
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Severe, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Additional Details: pt received Tdap and Meningitis vaccines. 2 mins after receiving vaccine, pt suddenly became pale and said she felt dizzy and was seeing some spots, then eyes rolled back into her eye and she became stiff and unresponsive. attempted to call name and touch pt with no response. pt left arm started to shake and pt head dropped to the side. EMS called and pt came too and did not recall event. pt then vomited and felt better afterward. refused EMS transfer to ED, Other Vaccines:  VaccineTypeBrand: menquadfi; Manufacturer: ; LotNumber: U7299AB; Route: IM; BodySite: right deltoid; Dose: 1; VaxDate: 06/14/2023
Age: 25.0
Sex: F
Vaccine: TDAP
Symptoms: Posture abnormal, Syncope, Tremor, Unresponsive to stimuli, Visual impairment
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Severe, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Additional Details: pt received Tdap and Meningitis vaccines. 2 mins after receiving vaccine, pt suddenly became pale and said she felt dizzy and was seeing some spots, then eyes rolled back into her eye and she became stiff and unresponsive. attempted to call name and touch pt with no response. pt left arm started to shake and pt head dropped to the side. EMS called and pt came too and did not recall event. pt then vomited and felt better afterward. refused EMS transfer to ED, Other Vaccines:  VaccineTypeBrand: menquadfi; Manufacturer: ; LotNumber: U7299AB; Route: IM; BodySite: right deltoid; Dose: 1; VaxDate: 06/14/2023
Age: 25.0
Sex: F
Vaccine: TDAP
Symptoms: Vomiting
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Severe, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Additional Details: pt received Tdap and Meningitis vaccines. 2 mins after receiving vaccine, pt suddenly became pale and said she felt dizzy and was seeing some spots, then eyes rolled back into her eye and she became stiff and unresponsive. attempted to call name and touch pt with no response. pt left arm started to shake and pt head dropped to the side. EMS called and pt came too and did not recall event. pt then vomited and felt better afterward. refused EMS transfer to ED, Other Vaccines:  VaccineTypeBrand: menquadfi; Manufacturer: ; LotNumber: U7299AB; Route: IM; BodySite: right deltoid; Dose: 1; VaxDate: 06/14/2023
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Injection site erythema, Injection site pain, Injection site pruritus, Neck pain
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: Injection site soreness/redness, spread up neck and to other shoulder. Rash is red, bumpy and itchy. Started 1 day after vaccine, patient saw a doctor and was prescribed prednisone and advised not to recieve the 2nd dose.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Rash, Rash erythematous, Rash pruritic
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: Injection site soreness/redness, spread up neck and to other shoulder. Rash is red, bumpy and itchy. Started 1 day after vaccine, patient saw a doctor and was prescribed prednisone and advised not to recieve the 2nd dose.
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Chills, Headache, Injection site erythema, Injection site pain, Malaise
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Chills-Mild, Systemic: Fever-Mild, Systemic: Headache-Mild, Additional Details: Patient complained of sore arm, can barely lift without pain, developed rash on injection arm 3 days later and is warmth to touch.  Didn't feel well a day after injection, had fever, chill, headache
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Pain, Pyrexia, Rash, Skin warm
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Chills-Mild, Systemic: Fever-Mild, Systemic: Headache-Mild, Additional Details: Patient complained of sore arm, can barely lift without pain, developed rash on injection arm 3 days later and is warmth to touch.  Didn't feel well a day after injection, had fever, chill, headache
Age: 52.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Error: Wrong Age for Vaccine Given-
Age: 21.0
Sex: F
Vaccine: HEP
Symptoms: Flushing, Hyperhidrosis, Nausea, Visual impairment, Vomiting
Clinical narrative: Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Medium, Systemic: Visual Changes/Disturbances-Medium, Systemic: Vomiting-Medium, Additional Details: Upon multiple follow-ups with patient the symptoms past before she left the pharmacy.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Pruritus
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: warm to touch, rash spreading over area on arm-Medium, Additional Details: none
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash, Skin warm
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: warm to touch, rash spreading over area on arm-Medium, Additional Details: none
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash Generalized-Mild, Systemic: Fever-Medium, Systemic: Weakness-Medium
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site swelling, Pyrexia, Rash
Clinical narrative: Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash Generalized-Mild, Systemic: Fever-Medium, Systemic: Weakness-Medium
Age: 50.0
Sex: M
Vaccine: PPV
Symptoms: Eye swelling, Mouth swelling, Swelling face, Swollen tongue
Clinical narrative: Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Other Vaccines:  VaccineTypeBrand: shingrix; Manufacturer: gsk; LotNumber: 94x3p; Route: intrmuscular; BodySite: left deltoid; Dose: 1; VaxDate: 06/14/2023
Age: 34.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Skin infection
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Skin infection requiring antibiotic treatment-Medium
Age: 24.0
Sex: M
Vaccine: HEP
Symptoms: Abdominal pain, Dizziness, Flushing, Hyperhidrosis, Nausea
Clinical narrative: Systemic: Abdominal Pain-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Additional Details: rescue sqaud was called.  pt had vomited and vitals were normal so he decilned to go to hospital, Other Vaccines:  VaccineTypeBrand: tenivac Td; Manufacturer: sanofi; LotNumber: u7745aa; Route: IM; BodySite: right arm; Dose: 1; VaxDate: 06/18/2023
Age: 24.0
Sex: M
Vaccine: HEP
Symptoms: Unresponsive to stimuli, Vomiting
Clinical narrative: Systemic: Abdominal Pain-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Additional Details: rescue sqaud was called.  pt had vomited and vitals were normal so he decilned to go to hospital, Other Vaccines:  VaccineTypeBrand: tenivac Td; Manufacturer: sanofi; LotNumber: u7745aa; Route: IM; BodySite: right arm; Dose: 1; VaxDate: 06/18/2023
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe
Age: 48.0
Sex: M
Vaccine: PNC20
Symptoms: Arthralgia, Dysphagia, Injection site bruising, Injection site pain, Injection site swelling
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Joint Pain-Medium, Other Vaccines:  VaccineTypeBrand: prevnar 20; Manufacturer: wyeth pfizer; LotNumber: gt0538; Route: im; BodySite: left; Dose: ; VaxDate: UNKNOWN
Age: 48.0
Sex: M
Vaccine: PNC20
Symptoms: Throat tightness
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Joint Pain-Medium, Other Vaccines:  VaccineTypeBrand: prevnar 20; Manufacturer: wyeth pfizer; LotNumber: gt0538; Route: im; BodySite: left; Dose: ; VaxDate: UNKNOWN
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Site: Redness at Injection Site-Mild
Age: 71.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Fatigue, Headache, Injection site bruising, Injection site erythema
Clinical narrative: Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Headache-Medium, Systemic: Joint Pain-Severe